NCT03953131View on ClinicalTrials.gov

Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Meningioma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

RADIATION

Gallium Ga 68-DOTATATE

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03953131 - Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas | Biotech Hunter | Biotech Hunter